1. Loss of improvement of angina between 1 and 7 years after aortocoronary bypass surgery. Correlation with changes in vein grafts and coronary arteries;Campeau, L.; Lesp6rance, J.; Hermann, J.; Corbara, F.; Grendin, C.M.; Bourassa, M.G.;Circulation,1979
2. Reoperation for recurrent angina;Brooks, N.; Honey, M.; Cattell, M.;Br Heart J; on a small number of patients, no benefit.'0,1979
3. The optimal dose of aspirin for the prevention of Hugenholtz PW. Long term follow-up after coronary thrombosis in patients with vascular disease is conartery bypass graft surgery. Progression and regression of troversial, and a low dose regimen has been recommended in the belief that this will inhibit platelet throboxane production but preserve prostacyclin synthesis in the vascular endothelium. This notion had not gained widespread acceptance at the time that the present trial was planned, and our dosage schedule was based on the augmentation by high dose disease in native coronary circulation and grafts;Brower, R.W.; Laird-Meeter, K.; Serruys, P.W.; Meester, G.T.;BrHeart J,1983
4. Pathologic changes in aortic coronary arterial saphenous vein grafts;Vlodaver, Z.; Edwards, J.E.;Circulation,1971
5. Pathologic changes in aortocoronary saphenous vein grafts;Unni, K.K.; Kottke, B.A.; Titus, J.L.; Frye, R.L.; Wallace, R.B.; Brown, A.L.;AmJI Cardiol,1974